Categories: Market Research

Automation In Biopharma Industry Market Growth Trajectory Through 2024-2033

The Automation In Biopharma Industry Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Automation In Biopharma Industry Market:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

According to The Business Research Company’s Automation In Biopharma Industry Global Market Report 2024, The automation in biopharma industry market size has grown strongly in recent years. It will grow from $1.94 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation.

The increasing adoption of robots in pharmaceutical manufacturing is expected to propel the growth of automation in biopharma industry market. Robots in pharmaceutical manufacturing refer to advanced automated systems and machines that perform various tasks in producing and packaging pharmaceutical products. Robots are often used in multiple applications in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, resulting in greater productivity, enhanced precision, reduced risk of contamination, and improved worker safety. For instance, in December 2021, according to the Association for Advancing Automation (A3), a US-based industry association promoting and advancing automation technologies, the North American robotics market achieved remarkable growth, with 29,000 units ordered valued at $1.48 billion in Q3 2021, with an impressive 37% increase in units sold. Moreover, the application of robotics in the life sciences, pharmaceutical, and biomedical sectors saw a substantial 36% increase in the first nine months of 2021. Therefore, the increasing adoption of robots in pharmaceutical manufacturing will drive the growth of automation in biopharma industry market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Technological advancements are a key trend gaining popularity in the automation in biopharma industry market. Major companies operating in the automation in biopharma industry market are focused on developing advanced product technologies to strengthen their position in the market. For instance, in September 2022, PerkinElmer Inc., a US-based company providing scientific solutions and technologies, launched the Cellaca PLX Image Cytometry System, a cutting-edge automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. The Cellaca PLX platform allows researchers to evaluate critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. This integrated system combines image cytometer hardware, software, validated consumables, and trackable data reporting, simplifying calibration and training requirements.

The automation in biopharma industry market report table of contents includes: